JPRN-UMIN000000792
Completed
Phase 2
Phase II study of gemcitabine/S-1 combination therapy in patients with non-resectable advanced biliary tract cancer - Phase II study of gemcitabine/S-1 combination therapy in patients with non-resectable advanced biliary tract cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- non-resectable biliary tract cancer or recurrent biliary tract cancer post surgical treatment
- Sponsor
- Kyoto University Hospital
- Enrollment
- 25
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\. Patients with interstitial pneumonia or pulmonary fibrosis 2\. Patients with uncontrollable diabetes mellitus, liver disease, angina pectoris or a new onset of myocardial infarction within 3 months 3\. Patients with severe active infection 4\. Patients who are pregnant or lactating, or have an intention to get pregnant 5\. Patients with a history of severe drug allery 6\. Patients with other serious comorbid disease 7\. Patinets with serious mental disease 8\. Patients who are judged inappropriate for the entry into the study by the investigater
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Phase II study of gemcitabine and S-1 combination therapy in advanced pancreatic cancer with malignant ascites.pancreatic cancer with ascitesJPRN-UMIN000003269ational Cancer Center Hospital East Hepatobiliary and Pancreatic Oncology Division36
Completed
Phase 2
Phase II/III study of Gemcitabine and S-1 (GS therapy) as Neoadjuvant chemotherapy for resectable pancreatic cancer (Prep-02/JSAP-05)JPRN-UMIN000009634Study group of preoperative therapy for pancreatic cancer (PREP)/Japanese Study Group of Adjuvant Therapy for pancreatic Cancer (JSAP)364
Recruiting
Phase 1
Phase I/II study of Gemcitabine and S-1 (GS therapy) as Neoadjuvant chemoradiationtherapy for borderline resectable pancreatic cancer (Prep-03/NS014-1)Borderline resectable pancreatic cancerJPRN-UMIN000014498Study group of preoperative therapy for pancreatic cancer (PREP)40
Recruiting
Phase 1
Prep-03Pancreatic cancerpancreatic cancerC535836JPRN-jRCTs021180045nno Michiaki40
Completed
Phase 2
Randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine and nanoparticle albumin-bound paclitaxel combination therapy as neoadjuvant chemotherapy for resectable/borderline resectable pancreatic ductal adenocarcinomaPancreatic ductal adenocarcinomaJPRN-UMIN000021484Clinical study group of Osaka university, Hepato-Biliary- Pancreatic group100